Repro Med Systems (KRMD) Reports In-Line Q1 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/18/2026
- Wall Street tumbles as worries about AI trade and high oil prices weigh
- Oil touches $110 a barrel for first time since May on Middle East, Russia supply fears
- Stay risk-off as higher real yields and AI volatility threaten stocks: BofA
- Apple’s first foldable iPhone sells out within minutes as preorders begin
- CoreWeave bond rout tests market's math on AI buildout
Tweet
Share
E-mailGet Alerts KRMD Hot Sheet
Join SI Premium – FREE
Repro Med Systems (NASDAQ: KRMD) reported Q1 EPS of ($0.05), in-line with the analyst estimate of ($0.05). Revenue for the quarter came in at $7.4 million versus the consensus estimate of $7.56 million.
GUIDANCE:
Repro Med Systems sees FY2023 revenue of $32.5-33.5 million, versus the consensus of $32.7 million.
For earnings history and earnings-related data on Repro Med Systems (KRMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Williams Trading Downgrades Birkenstock Holding plc (BIRK) to Sell, 'Stock Less Comfortable than the Shoes'
- VCI Global posts revenue drop and net loss in 1H2026 amid pivot
- ManpowerGroup (MAN) Reports In-Line Q3 EPS; offers guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
